Mainstream

ScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectory

ScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectory

Post ContentscphRead More

You might also be interested in reading Warren Buffett has created a $348bn question for his successor.

May 15, 2025
In Mainstream